Fanconi’s Anemia Effect or Sickle Cell Anemia Effect: That is the Question

References

• Khincha PP, Savage SA. Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol. 2013;50(4):333–347
   PubMed Web of Science ®Google Scholar
• Garaycoechea JI, Patel KJ. Why does the bone marrow fail in Fanconi anemia? Blood. 2014;123(1):26–34
   PubMed Web of Science ®Google Scholar
• Alter BP, Rosenberg PS, Day T, et al. Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes. Br J Haematol. 2013;162(4):542–546
   PubMed Web of Science ®Google Scholar
• Gumruk F, Tavil B, Balta G, et al. Significance of fetal hemoglobin values in detection of heterozygotes in fanconi anemia: Reevaluation of fetal hemoglobin values by a sensitive method. J Pediatr Hematol Oncol. 2008;30(12):896–899
   PubMed Web of Science ®Google Scholar
• Akinsheye I, Alsultan A, Solovieff N, et al. Fetal hemoglobin in sickle cell anemia. Blood. 2011;118(1):19–27
   PubMed Web of Science ®Google Scholar
• Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37–47
   PubMed Web of Science ®Google Scholar
• Figueiredo MS, Steinberg MH. Fetal hemoglobin in sickle cell anemia: Examination of phylogenetically conserved sequences within the locus control region but outside the cores of hypersensitive sites 2 and 3. Blood Cells Mol Dis. 1997;23(2):188–200
   PubMed Web of Science ®Google Scholar
• Rosatelli MC, Altay Ç, Oner R, et al. β-Globin haplotype and XmnI polymorphism at position Gγ −158 and Hb F production in Fanconi’s anemia. Haematologica. 1992;77(2):106–109
   PubMedGoogle Scholar
• Altay Ç, Alikaşifoglu M, Kara A, et al. Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience. Clin Genet. 1997;51(5):296–302
   PubMed Web of Science ®Google Scholar
• Yarali N, Fişgin T, Duru F, Kara A. Coexistence of sickle cell trait and Fanconi anemia in a child. Pediatr Hematol Oncol. 2002;19(4):283–285
   PubMed Web of Science ®Google Scholar
• Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: Results of a 17-year, single-center trial (LaSHS). Blood. 2010;115(12):2354–2363
   PubMed Web of Science ®Google Scholar
• Snyder RD. The role of deoxynucleoside triphosphate pools in the inhibition of DNA-excision repair and replication in human cells by hydroxyurea. Mutat Res. 1984;131(3–4):163–172
   PubMed Web of Science ®Google Scholar
• Friedrisch JR, Prá D, Maluf SW, et al. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea. Mutat Res. 2008;649(1–2):213–220
   PubMed Web of Science ®Google Scholar
• McGann PT, Flanagan JM, Howard TA, et al. Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY-HUG Phase III Clinical Trial. Pediatr Blood Cancer. 2012;59(2):254–257
   PubMed Web of Science ®Google Scholar
• Schindler D, Hoehn H. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet. 1988;43(4):429–435
   PubMed Web of Science ®Google Scholar
• Müller LU, Milsom MD, Harris CE, et al. Overcoming reprogramming resistance of Fanconi anemia cells. Blood. 2012;119(23):5449–5457
   PubMed Web of Science ®Google Scholar
• Bunn HF, Nathan DG, Dover GJ, et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood. 2010;116(5):687–692
   PubMed Web of Science ®Google Scholar
• Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294(1):81–90
   PubMed Web of Science ®Google Scholar
• Bolisetty S, Jaimes EA. Mitochondria and reactive oxygen species: Physiology and pathophysiology. Int J Mol Sci. 2013;14(3):6306–6344
   PubMed Web of Science ®Google Scholar
• Gregory JJ Jr, Wagner JE, Verlander PC, et al. Somatic mosaicism in Fanconi anemia: Evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci USA. 2001;98(5):2532–2537
   PubMed Web of Science ®Google Scholar